Volume 16, Number 4—April 2010
CME ACTIVITY - Research
Community-associated Methicillin-Resistant Staphylococcus aureus Strains in Pediatric Intensive Care Unit1
Medscape, LLC is pleased to provide online continuing medical education (CME) for this journal article, allowing clinicians the opportunity to earn CME credit. This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Medscape, LLC and Emerging Infectious Diseases. Medscape, LLC is accredited by the ACCME to provide continuing medical education for physicians. Medscape, LLC designates this educational activity for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity. All other clinicians completing this activity will be issued a certificate of participation. To participate in this journal CME activity: (1) review the learning objectives and author disclosures; (2) study the education content; (3) take the post-test and/or complete the evaluation at www.medscapecme.com/journal/eid; (4) view/print certificate.
Upon completion of this activity, participants will be able to:
Identify risk factors among children for being a community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) carrier.
Recognize the benefits of screening for MRSA colonization in children being admitted to the hospital.
Predict a consequence of undetected CA-MRSA carriers admitted to a hospital setting.
Carol Snarey, Copyeditor, Emerging Infectious Diseases. Disclosure: Carol Snarey has disclosed no relevant financial relationships.
Charles P. Vega, MD, Associate Professor; Residency Director, Department of Family Medicine, University of California, Irvine, CA, USA. Disclosure: Charles P. Vega, MD, has disclosed no relevant financial relationships.
Disclosures: Aaron M. Milstone, MD, MHS, has disclosed the following relevant financial relationship: received grants for clinical research from Sage Products, Inc. Karen C. Carroll, MD, has disclosed the following relevant relationships: served as an advisor or consultant for Quidel Diagnostics; OpGen, Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; received grants for clinical research from BD GeneOhm; Ibis Biosciences, Inc.; MicroPhage, Inc. Tracy Ross, BS, and K. Alexander Shangraw, MSPH, have disclosed no relevant financial relationships. Trish M. Perl, MD, MSc, has disclosed the following relevant financial relationships: served as an advisor or consultant for Cadence Pharmaceuticals; 3M; TheraDoc Inc.; received grants for clinical research from US Centers for Disease Control and Prevention; Merck & Co., Inc.; Sage Products, Inc.; US Department of Veterans Affairs.
Comments to the EID Editors
Please contact the EID Editors via our Contact Form.
- Page created: December 23, 2010
- Page last updated: December 23, 2010
- Page last reviewed: December 23, 2010
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)